Skip to main content
SpringerLink
Log in

Ier Congrès français Coeur & Cancer : le début d’une belle histoire attendue

Compte rendu du congrès Coeur & Cancer (25–26 juin 2015, Paris)

The Ist French heart & cancer congress: the start of a wonderful story

Report from the heart & cancer congress (25–26 June 2015, Paris)

  • Comptes-Rendus De Congrès / Congresses, Conferences
  • Published:
Oncologie

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Plana JC, Galderisi M, Barac A, et al (2014) Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 27:911–39

    Article  PubMed  Google Scholar 

  2. Cardinale D, Sandri MT, Martinoni A, et al (2000) Left ventricular dysfunction predicted by early troponin I release after highdose chemotherapy. J Am Coll Cardiol 36:517–22

    Article  CAS  PubMed  Google Scholar 

  3. Cardinale D, Colombo A, Torrisi R, et al (2010) Trastuzumabinduced cardiotoxicity: clinical and prognostic implications of troponin I evaluation. J Clin Oncol 28:3910–6

    Article  CAS  PubMed  Google Scholar 

  4. Sawaya H, Sebag IA, Plana JC, et al (2012) Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging 5:596–603

    Article  PubMed  PubMed Central  Google Scholar 

  5. Fallah-Rad N, Walker JR, Wassef A, et al (2011) The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. Am Coll Cardiol 57:2263–70

    Article  CAS  Google Scholar 

  6. Girinsky T, M’Kacher R, Lessard N, et al (2014) Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: results and risk factor analysis. Int J Radiat Oncol Biol Phys 89:59–66

    Article  PubMed  Google Scholar 

  7. Darby SC, Ewertz M, Mc Gale P, et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987–98

    Article  CAS  PubMed  Google Scholar 

  8. Van Nimwegen FA, Schaapveld M, Janus CP, et al (2015) Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. JAMA Intern Med 175(6):1007–17

    Article  PubMed  Google Scholar 

  9. Mège A, Ziouèche A, Pourel N, Chauvet B. (2011) Radiationrelated heart toxicity. Cancer Radiother 15:495–503

    Article  PubMed  Google Scholar 

  10. Wu S, Chen JJ, Kudelka A, et al (2008) Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis. Lancet Oncol 9:117–23

    Article  CAS  PubMed  Google Scholar 

  11. Lévy BI (2009) Blood pressure as a potential biomarker of the efficacy angiogenesis inhibitor. Ann Oncol 20:200–3

    Article  PubMed  Google Scholar 

  12. Keating NL, O’Malley AJ, Smith MR (2006) Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 24:4448–56

    Article  CAS  PubMed  Google Scholar 

  13. Bosco C, Bosnyak Z, Malmberg A, et al (2014) Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis. Eur Urol 68:386–96

    Article  PubMed  Google Scholar 

  14. Albertsen PC, Klotz L, Tombal B, et al (2014) Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist. Eur Urol 65:565–73

    Article  CAS  PubMed  Google Scholar 

  15. http://www.thrombose-cancer.com/

  16. https://www.itaccme.com/en/practice-guidelines/guidelines-app

  17. Société française d’anesthésie et de réanimation (Sfar) (2015) Conférence d’experts sur le tabagisme périopératoire. http://www.sfar.org

  18. Rivera C, Rivera S, Fabre E, et al (2015) Consequences of tobacco smoking on lung cancer treatments. Rev Pneumol Clin 72:136–41

    Article  PubMed  Google Scholar 

  19. Browman GP, Wong G, Hodson I, et al (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328:159–63

    Article  CAS  PubMed  Google Scholar 

  20. Report (2014) The health consequences of smoking— 50 years of progress: a report of the surgeon general. http://www.surgeongeneral. gov/library/reports/50-years-of-progress/

  21. Ibrahim EM, Al Homaidh A (2011) Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol 28:753–65

    Article  PubMed  Google Scholar 

  22. Farmakis D, Parissis J, Filippatos G (2014) Insights into oncocardiology: atrial fibrillation in cancer. J Am Coll Cardiol 63:945–53

    Article  PubMed  Google Scholar 

  23. Ewer MS, Ewer SM (2010) Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Nat Rev Cardiol 7:564–75

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre de radiothérapie Hartmann, hôpital Américain de Paris, 4, rue Kléber, CS 90004, F-92309, Levallois-Perret cedex, France

    A. Toledano

  2. Cardiologie, hôpital Lariboisière, 2, rue Ambroise-Paré, F-75010, Paris, France

    A. Cohen Solal

Authors
  1. A. Toledano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Cohen Solal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to A. Toledano or A. Cohen Solal.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Toledano, A., Cohen Solal, A. Ier Congrès français Coeur & Cancer : le début d’une belle histoire attendue. Oncologie 18, 424–428 (2016). https://doi.org/10.1007/s10269-016-2646-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-016-2646-4

Search

Navigation